Toggle Offcanvas
...
 
Tofacitinib Tenders

Tofacitinib Tenders

View Tofacitinib tenders, RFPs and contracts. Bid on readily available Tofacitinib tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Tofacitinib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Tofacitinib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Tofacitinib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Tofacitinib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

11 Live Notices for Tofacitinib Tenders

Showing 1 to 11

Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Tofacitinib, Atc L04Af01 For The Period 01.09.2025 - 31.08.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Jul 2025
deadline05 Jul 2028
Open House Medicinal Department Treaties Tofacitinib, Atc L04Af01
country Germany
posting date16 Jun 2025
deadline03 Jun 2027
Open House Medicinal Department Treaties Tofacitinib, Atc L04Af01
country Germany
posting date16 Jun 2025
deadline03 Jun 2027
Open House Pharmaceutical Discounts On The Active Ingredient Tofacitinib, Atc L04Af01
country Germany
posting date13 Mar 2025
deadline28 Feb 2027
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date12 Mar 2025
deadline05 Dec 2025
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
country Germany
posting date14 Jun 2024
deadline01 Jun 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tofacitinib
country Germany
posting date03 Oct 2023
deadline10 Sep 2025
Items: Tab Tofacitinib 5 Mgquantity: 180
country India
posting date30 Jul 2025
deadline09 Aug 2025
Tofacitinib 5Mg Tab.
country India
posting date26 Jul 2025
deadline05 Aug 2025

Share Share this page